P12—Fabry Disease in Latin America: A Report From the Fabry Registry

Fabry disease is a rare lysosomal storage disorder caused by a deficient activity of the lysosomal enzyme ?-galactosidase A. The Fabry Registry is a global, observational, and voluntary program designed to collect clinical data related to the onset, progression, and treatment of Fabry disease.

Autores:

Tipo de recurso:

Fecha de publicación:: 2012

Institución:: Universidad del Rosario

Repositorio:: Repositorio EdocUR - U. Rosario

Idioma:: eng

id	EDOCUR2_6cda635c4287d1aa1c2d1d69b920050d
oai_identifier_str	oai:repository.urosario.edu.co:10336/25950
network_acronym_str	EDOCUR2
network_name_str	Repositorio EdocUR - U. Rosario
repository_id_str
spelling	5821e96e-9e07-4d26-a6bb-eb4c08ef27c3-146d50aa4-bb54-49ae-860b-89b7a9645c28-1ca2d60ff-2ea4-496e-8bb1-1b5091cf65ec-10b9c6165-e144-4aa3-92b0-68b6f4f1187b-1f9bf9a35-2889-4ccb-90bb-003f7b226daf-11730e91a-3ada-408a-8913-9c2eeb35e34b-12020-08-06T16:20:18Z2020-08-06T16:20:18Z2012-04-01Fabry disease is a rare lysosomal storage disorder caused by a deficient activity of the lysosomal enzyme ?-galactosidase A. The Fabry Registry is a global, observational, and voluntary program designed to collect clinical data related to the onset, progression, and treatment of Fabry disease.application/pdfhttps://doi.org/10.1016/j.clinthera.2012.03.042ISSN: 1521-7035EISSN: 1521-6616https://repository.urosario.edu.co/handle/10336/25950engElsevierNo. 4e23 Clinical TherapeuticsVol. 34Clinical Therapeutics, ISSN:1521-7035 ; EISSN:1521-6616, Vol.34, No.4 (April, 2012); pp.e23https://www.clinicaltherapeutics.com/article/S0149-2918(12)00192-0/fulltextRestringido (Acceso a grupos específicos)http://purl.org/coar/access_right/c_16ecClinical Therapeuticsinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURMedical and Health SciencesPharmacology and Pharmaceutical SciencesP12—Fabry Disease in Latin America: A Report From the Fabry RegistryP12 — Enfermedad de Fabry en América Latina: un informe del registro de FabryarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Martins, A.M.Ospina, S.Villalobos, J.Politei, J.Varas, C.Registry Coordinators, Latin America10336/25950oai:repository.urosario.edu.co:10336/259502021-06-03 00:50:22.146https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv	P12—Fabry Disease in Latin America: A Report From the Fabry Registry
dc.title.TranslatedTitle.spa.fl_str_mv	P12 — Enfermedad de Fabry en América Latina: un informe del registro de Fabry
title	P12—Fabry Disease in Latin America: A Report From the Fabry Registry
spellingShingle	P12—Fabry Disease in Latin America: A Report From the Fabry Registry Medical and Health Sciences Pharmacology and Pharmaceutical Sciences
title_short	P12—Fabry Disease in Latin America: A Report From the Fabry Registry
title_full	P12—Fabry Disease in Latin America: A Report From the Fabry Registry
title_fullStr	P12—Fabry Disease in Latin America: A Report From the Fabry Registry
title_full_unstemmed	P12—Fabry Disease in Latin America: A Report From the Fabry Registry
title_sort	P12—Fabry Disease in Latin America: A Report From the Fabry Registry
dc.subject.keyword.spa.fl_str_mv	Medical and Health Sciences Pharmacology and Pharmaceutical Sciences
topic	Medical and Health Sciences Pharmacology and Pharmaceutical Sciences
description	Fabry disease is a rare lysosomal storage disorder caused by a deficient activity of the lysosomal enzyme ?-galactosidase A. The Fabry Registry is a global, observational, and voluntary program designed to collect clinical data related to the onset, progression, and treatment of Fabry disease.
publishDate	2012
dc.date.created.spa.fl_str_mv	2012-04-01
dc.date.accessioned.none.fl_str_mv	2020-08-06T16:20:18Z
dc.date.available.none.fl_str_mv	2020-08-06T16:20:18Z
dc.type.eng.fl_str_mv	article
dc.type.coarversion.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv	Artículo
dc.identifier.doi.none.fl_str_mv	https://doi.org/10.1016/j.clinthera.2012.03.042
dc.identifier.issn.none.fl_str_mv	ISSN: 1521-7035 EISSN: 1521-6616
dc.identifier.uri.none.fl_str_mv	https://repository.urosario.edu.co/handle/10336/25950
url	https://doi.org/10.1016/j.clinthera.2012.03.042 https://repository.urosario.edu.co/handle/10336/25950
identifier_str_mv	ISSN: 1521-7035 EISSN: 1521-6616
dc.language.iso.spa.fl_str_mv	eng
language	eng
dc.relation.citationIssue.none.fl_str_mv	No. 4
dc.relation.citationStartPage.none.fl_str_mv	e23
dc.relation.citationTitle.none.fl_str_mv	Clinical Therapeutics
dc.relation.citationVolume.none.fl_str_mv	Vol. 34
dc.relation.ispartof.spa.fl_str_mv	Clinical Therapeutics, ISSN:1521-7035 ; EISSN:1521-6616, Vol.34, No.4 (April, 2012); pp.e23
dc.relation.uri.spa.fl_str_mv	https://www.clinicaltherapeutics.com/article/S0149-2918(12)00192-0/fulltext
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_16ec
dc.rights.acceso.spa.fl_str_mv	Restringido (Acceso a grupos específicos)
rights_invalid_str_mv	Restringido (Acceso a grupos específicos) http://purl.org/coar/access_right/c_16ec
dc.format.mimetype.none.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Elsevier
dc.source.spa.fl_str_mv	Clinical Therapeutics
institution	Universidad del Rosario
dc.source.instname.none.fl_str_mv	instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv	reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv	Repositorio institucional EdocUR
repository.mail.fl_str_mv	edocur@urosario.edu.co
_version_	1814167667262619648

P12—Fabry Disease in Latin America: A Report From the Fabry Registry

Publicaciones similares